Karyopharm Therapeutics
12 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm... Read more
Org chart
Richard Paulson
President & CEO
Richard Paulson
Collapse
Sohanya Cheng
Chief Commercial Officer & Head of Business Development
Reshma Rangwala
Chief Medical Officer & Head of Research
Lisa DiPaolo
Chief Human Resources Officer
James Accumanno
Chief Compliance Officer
Stuart Poulton
Chief Development Officer
Mike Mano
SVP & General Counsel
Amama Sadiq
SVP, Global Medical & Scientific Affairs
Brian Austad
SVP, Pharmaceutical Sciences
Stephen Li
Senior Vice President, Regulatory Affairs
Kristin Abate
Vp, Accounting & Corporate Controller
Similar companies
Prescient Healthcare Group
24 followers
nference
4 followers
Esperion Therapeutics
2 followers
Recursion Pharmaceuticals
6 followers
Intra-Cellular Therapies
1 follower
Corcept Therapeutics
1 follower
Azzur Group
4 followers
Silk Road Medical
3 followers
Quality Chemical Laboratories
1 follower
Bristol-Myers Squibb
168 followers
Omnicell
20 followers
Discover companies